Physician David Steenblock interviewed by CoreBrain on turnaround treatments for incurable diseases
Industry: Healthcare
Physician David Steenblock interviewed by CoreBrain Journal (podcast) concerning his innovative treatments for many major diseases & medical conditions
San Clemente, CA (PRUnderground) October 27th, 2017
There are unique and effective medical treatments for many treatment resistant and “incurable” cardiovascular, brain and central nervous system diseases and conditions that most doctors know nothing about. This is because they were developed and are used in one clinic alone in southern California.
Over the past four decades physician David Steenblock, M.S., D.O. and his team of medical and research professionals and consultants have done trailblazing work that has produced impressive, clinically significant improvements in people with Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s, autism, cerebral palsy, Parkinson’s disease, stroke (acute & chronic), and traumatic brain injury (TBI).
Now, in a wide ranging, riveting, fast paced one-hour CoreBrain Journal podcast interview hosted by psychiatrist Charles Parker, Dr. Steenblock shares details about how specific combinations of nonembryonic stem cells, hyperbaric oxygen, drugs and natural compounds (including those that eliminate inactive or dying cells in the body), chelation detox, enhanced external counterpulsation (EECP) and other therapeutic measures, given at the right time and in the right way and in the right doses, has benefitted thousands of his patients.
The CoreBrain Journal podcast can be accessed by going to https://www.corebrainjournal.com/2017/10/163-brain-regeneration-stroke-tbi-cerebral-palsy-steenblock/ (There is a button there readers can click to listen to the podcast using iTunes).
About David A. Steenblock, D.O., Inc.
Dr. David Steenblock is a medical innovator whose work has produced unique and effective ways to accelerate recovery, healing and regeneration in people struggling with many chronic diseases and conditions. Since 2000 he has focused on developing regenerative and stem cell-based ways to treat ALS, Cerebral Palsy and many other chronic, degenerative diseases.